COVID-19流行病对希腊支气管炎流行病学的影响
Athina Koloi1, Dimitra Dimopoulou1, Dimitris Papakonstantinou2
1Second Department of Pediatrics, School of Medicine, "P. and A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Medicina (Kaunas, Lithuania)
|October 29, 2025
概括
随着COVID-19大流行,希腊的支气管炎流行病学发生了重大变化,导致限制措施期间住院病例急剧下降. 支气管炎的严重程度保持不变,强调需要持续监测.
科学领域:
- 儿童传染病 儿童传染病
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 急性支气管炎是全球婴儿住院和疾病的主要原因.
- COVID-19 流行病明显影响了呼吸道感染的全球流行病学.
- 了解这些变化对于管理儿科呼吸道疾病至关重要.
研究的目的:
- 评估COVID-19限制措施期间和之后希腊支气管炎流行病学的变化.
- 将这些变化与大流行前的流行病学模式进行比较.
- 评估对住院率,季节性和疾病严重程度的影响.
主要方法:
- 对1505例婴儿 (0-24个月) 因支气管炎住院的回顾性分析.
- 2017年11月至2024年9月,从希腊一家三级儿科医院收集的数据.
- 在七个不同的季节期进行分析,以确定趋势.
主要成果:
- 支气管炎住院病例在2020-2021年减少了98%,随后恢复到大流行前的水平,随后在2022-2023年增加了58.7%.
- 支气管炎的季节性发作在2021-2022年早些时候发生了变化,但后来又恢复到了大流行前的模式.
- 2020-2021年,呼吸道同胞性病毒 (RSV) 阳性病例显著下降,疾病严重程度在所有时期保持一致.
结论:
- COVID-19大流行严重影响了希腊的支气管炎流行病学,改变了住院率和季节性分布.
- 疾病的严重程度没有变化,这表明大流行的影响主要是传播动态.
- 持续监测支气管炎和RSV是至关重要的,特别是新的预防策略,如母体RSV疫苗接种和单克隆抗体.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K